OnKure CMO granted 110,000 stock options
OnKure Therapeutics, Inc. Chief Medical Officer Samuel Agresta reported a compensation-related grant of 110,000 employee stock options to buy Class A Common Stock.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
OnKure Therapeutics, Inc. Chief Medical Officer Samuel Agresta reported a compensation-related grant of 110,000 employee stock options to buy Class A Common Stock. The options carry an exercise price of $4.07 per share and expire on March 31, 2036.
According to the filing, 1/48th of the options will vest on May 1, 2026 and then monthly thereafter, as long as he continues as a service provider. Following this grant, he holds 110,000 derivative securities directly, with no open-market buying or selling reported.
Insider Trade Summary
Grant/Award: 110,000 shares
Grant/Award
1 txn
Insider
Agresta Samuel
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (right to buy) | 110,000 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (right to buy) — 110,000 contracts (Direct)
Footnotes (1)
- F1. 1/48th of the shares subject to the option shall vest on May 1, 2026 and each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
Key Figures
Option grant size: 110,000 options
Exercise price: $4.07 per share
Expiration date: March 31, 2036
+1 more
4 metrics
Option grant size
110,000 options
Employee stock option grant reported on April 1, 2026
Exercise price
$4.07 per share
Exercise price for Class A Common Stock under options
Expiration date
March 31, 2036
Option expiration for granted employee stock options
Post-grant derivative holdings
110,000 derivative securities
Total options held directly after the grant
Key Terms
Employee Stock Option, Class A Common Stock, exercise price, vesting
4 terms
Employee Stock Option financial
"Employee Stock Option (right to buy)"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
Class A Common Stock financial
"underlying security title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
exercise price financial
"conversion or exercise price of 4.0700 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"1/48th of the shares subject to the option shall vest on May 1, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did OnKure Therapeutics (OKUR) disclose in this Form 4 for Samuel Agresta?
OnKure Therapeutics reported a grant of 110,000 employee stock options to Chief Medical Officer Samuel Agresta. These options are compensation, not an open-market trade, and give him the right to buy Class A Common Stock at a fixed exercise price.
How many OnKure (OKUR) stock options were granted and at what exercise price?
Samuel Agresta received 110,000 employee stock options for OnKure Class A Common Stock. The options have an exercise price of $4.07 per share, meaning he can buy the shares at that price once the options vest and are exercisable.
When do Samuel Agresta’s OnKure (OKUR) options vest under this Form 4 filing?
The filing states that 1/48th of the option shares will vest on May 1, 2026, with additional 1/48th portions vesting each month thereafter. Vesting is contingent on Samuel Agresta continuing as a service provider through each applicable vesting date.
Are the OnKure (OKUR) option grants to Samuel Agresta an open-market purchase or compensation?
The transaction is a compensation-related grant, not an open-market purchase. The Form 4 uses transaction code “A” for a grant or award acquisition, reflecting employee stock options awarded to the Chief Medical Officer at a $4.07 exercise price.
When do Samuel Agresta’s OnKure (OKUR) stock options expire?
The employee stock options granted to Samuel Agresta expire on March 31, 2036. He can exercise vested options any time before that expiration date, subject to the company’s equity plan terms and his continued service-based vesting conditions.
How many derivative securities does Samuel Agresta hold in OnKure (OKUR) after this grant?
After the reported grant, Samuel Agresta holds 110,000 derivative securities related to OnKure Class A Common Stock. These consist entirely of the newly granted employee stock options reported in this Form 4, held as direct ownership.
AI-generated analysis. How Rhea-AI works. Not financial advice.
